Normal view MARC view ISBD view

Molecular Vaccines [electronic resource] :From Prophylaxis to Therapy - Volume 2 / edited by Matthias Giese.

by Giese, Matthias [editor.]; SpringerLink (Online service).
Material type: materialTypeLabelBookPublisher: Cham : Springer International Publishing : 2014.Description: XXVIII, 870 p. 98 illus., 74 illus. in color. online resource.ISBN: 9783319009780.Subject(s): Medicine | Immunology | Vaccines | Biomedicine | Vaccine | Immunology | Molecular MedicineDDC classification: 615.372 Online resources: Click here to access online
Contents:
Non-infectious and non-cancer vaccines -- Adjuvants and nanotechnology -- In silico and delivery systems -- Patenting, manufacturing, registration.
In: Springer eBooksSummary: This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Practical perspectives of patentability of vaccines are discussed. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
QR189-189.5 (Browse shelf) Available
Long Loan MAIN LIBRARY
RM281 (Browse shelf) Available

Non-infectious and non-cancer vaccines -- Adjuvants and nanotechnology -- In silico and delivery systems -- Patenting, manufacturing, registration.

This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Practical perspectives of patentability of vaccines are discussed. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

There are no comments for this item.

Log in to your account to post a comment.
@ Jomo Kenyatta University Of Agriculture and Technology Library

Powered by Koha